Aghajanian C - Search Results

1

A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.

Barakat RR, Almadrones L, Venkatraman ES, Aghajanian C, Brown C, Shapiro F, Curtin JP, Spriggs D. Barakat RR, et al. Among authors: aghajanian c. Gynecol Oncol. 1998 Apr;69(1):17-22. doi: 10.1006/gyno.1998.4973. Gynecol Oncol. 1998. PMID: 9570993 Clinical Trial.

2

The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer.

Gogas H, Shapiro F, Aghajanian C, Fennelly D, Almadrones L, Hoskins WJ, Spriggs DR. Gogas H, et al. Among authors: aghajanian c. Gynecol Oncol. 1996 Apr;61(1):22-6. doi: 10.1006/gyno.1996.0090. Gynecol Oncol. 1996. PMID: 8626111

3

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.

Fennelly D, Aghajanian C, Shapiro F, O'Flaherty C, McKenzie M, O'Connor C, Tong W, Norton L, Spriggs D. Fennelly D, et al. Among authors: aghajanian c. J Clin Oncol. 1997 Jan;15(1):187-92. doi: 10.1200/JCO.1997.15.1.187. J Clin Oncol. 1997. PMID: 8996141 Clinical Trial.

4

Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer.

Fennelly DW, Aghajanian C, Shapiro F, O'Flaherty C, O'Connor K, Curtin JP, Crown JP, Hoskins WJ, Spriggs DR. Fennelly DW, et al. Among authors: aghajanian c. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-26-S2-30. Semin Oncol. 1997. PMID: 9045332 Clinical Trial.

5

Salvage weekly paclitaxel in recurrent ovarian cancer.

Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D. Abu-Rustum NR, et al. Among authors: aghajanian c. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-62-S15-67. Semin Oncol. 1997. PMID: 9346225 Clinical Trial.

6

Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.

Aghajanian C, Brown C, O'flaherty C, Fleischauer A, Curtin J, Roemeling R, Spriggs DR. Aghajanian C, et al. Gynecol Oncol. 1997 Nov;67(2):127-30. doi: 10.1006/gyno.1997.4841. Gynecol Oncol. 1997. PMID: 9367694 Clinical Trial.

7

Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.

Wang E, Ma WJ, Aghajanian C, Spriggs DR. Wang E, et al. Among authors: aghajanian c. Cancer Res. 1997 Dec 1;57(23):5426-33. Cancer Res. 1997. PMID: 9393771

8

Management of malignant germ cell tumors of the ovary.

Abu-Rustum NR, Aghajanian C. Abu-Rustum NR, et al. Among authors: aghajanian c. Semin Oncol. 1998 Apr;25(2):235-42. Semin Oncol. 1998. PMID: 9562457 Review.

9

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.

Aghajanian C, Fennelly D, Shapiro F, Waltzman R, Almadrones L, O'Flaherty C, O'Conner K, Venkatraman E, Barakat R, Curtin J, Brown C, Reich L, Wuest D, Norton L, Hoskins W, Spriggs DR. Aghajanian C, et al. J Clin Oncol. 1998 May;16(5):1852-60. doi: 10.1200/JCO.1998.16.5.1852. J Clin Oncol. 1998. PMID: 9586901 Clinical Trial.

10

Chemotherapy in gynecologic cancer.

Sabbatini P, Aghajanian C, Spriggs D. Sabbatini P, et al. Among authors: aghajanian c. Curr Opin Oncol. 1998 Sep;10(5):429-33. doi: 10.1097/00001622-199809000-00010. Curr Opin Oncol. 1998. PMID: 9800113 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page